PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

He Hong-Lin; Lee Ying-En; Shiue Yow-Ling; Lee Sung-Wei; Lin Li-Ching; Chen Tzu-Ju; Wu Ting-Feng; Li Chien-Feng

首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

【24h】

PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

机译：PLA2G2A过表达与接受新辅助同时放化疗的直肠癌患者不良的治疗反应和不良的预后相关

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsThe aim of this study was to investigate the prognostic impact of group IIA phospholipase A2 (PLA2G2A) expression and its role in predicting the response to neoadjuvant concurrent cheomoradiotherapy (CCRT) in rectal cancer.

机译：目的本研究的目的是研究IIA组磷脂酶A2（PLA2G2A）表达对预后的影响及其在预测直肠癌对新辅助同时放化疗（CCRT）的反应中的作用。

著录项

来源
《Histopathology: Official Journal of the British Division of the International Academy of Pathology》 |2015年第7期|共12页
作者
He Hong-Lin; Lee Ying-En; Shiue Yow-Ling; Lee Sung-Wei; Lin Li-Ching; Chen Tzu-Ju; Wu Ting-Feng; Li Chien-Feng;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类病理学;
关键词
CCRT; chemoradiotherapy; PLA2G2A; rectal cancer;

机译：CCRT;放化疗;PLA2G2A;直肠癌;

相似文献

外文文献
中文文献
专利

1. PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy [J] . He Hong-Lin, Lee Ying-En, Shiue Yow-Ling, Histopathology: Official Journal of the British Division of the International Academy of Pathology . 2015,第7期

机译：PLA2G2A过表达与接受新辅助同时放化疗的直肠癌患者不良的治疗反应和不良的预后相关
2. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Poor Survival in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy [J] . Ke T. M., Yang C. C. International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：中性粒细胞到淋巴细胞比和血小板到淋巴细胞比率预测接受Neoadjuvant Conturrent ChemoRAdiach的直肠癌患者的差
3. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy [J] . Chien-Feng Li, Hong-Lin He, Jaw-Yuan Wang, Journal of Clinical Pathology . 2014,第12期

机译：成纤维细胞生长因子受体2过表达预示着接受新辅助放化疗的直肠癌患者预后不良
4. Radiomics analysis of DWI data to identify the rectal cancer patients qualified for local excision after neoadjuvant chemoradiotherapy [C] . Zhenchao Tang, Zhenyu Liu, Xiaoyan Zhang, SPIE Medical Imaging Conference . 2018

机译：DWI数据的放射线学分析，以鉴定新辅助放化疗后符合局部切除资格的直肠癌患者
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response [O] . Filip Pazdirek, Marek Minarik, Lucie Benesova, 2020

机译：监测接受Neoadjuvant伴随化疗的直肠癌患者血浆循环肿瘤DNA的早期变化：预后评估和治疗反应预测
7. High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy [O] . Te-Min Ke, Li-Ching Lin, Chun-Che Huang, 2020

机译：高中性粒细胞对淋巴细胞比和血小板到淋巴细胞比率预测接受Neoadjuvant同时进行化学疗法的直肠癌患者的存活率差

PLA2G2A overexpression is associated with poor therapeutic response and inferior outcome in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

摘要

著录项

相似文献

相关主题

期刊订阅